BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao J, Nesbitt H, Logan K, Burnett K, White B, Jack IG, Taylor MA, Love M, Callan B, McHale AP, Callan JF. An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer. Eur J Pharm Biopharm 2020;157:233-40. [PMID: 33222772 DOI: 10.1016/j.ejpb.2020.10.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gao J, Logan KA, Nesbitt H, Callan B, McKaig T, Taylor M, Love M, McHale AP, Griffith DM, Callan JF. A single microbubble formulation carrying 5-fluorouridine, Irinotecan and oxaliplatin to enable FOLFIRINOX treatment of pancreatic and colon cancer using ultrasound targeted microbubble destruction. J Control Release 2021;338:358-66. [PMID: 34481018 DOI: 10.1016/j.jconrel.2021.08.050] [Reference Citation Analysis]
2 Entzian K, Aigner A. Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment. Pharmaceutics 2021;13:1135. [PMID: 34452096 DOI: 10.3390/pharmaceutics13081135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang P, Chen D, Li L, Sun K. Charge reversal nano-systems for tumor therapy. J Nanobiotechnology 2022;20:31. [PMID: 35012546 DOI: 10.1186/s12951-021-01221-8] [Reference Citation Analysis]
4 Lindemann MC, Luttke T, Nottrodt N, Schmitz-Rode T, Slabu I. FEM based simulation of magnetic drug targeting in a multibranched vessel model. Comput Methods Programs Biomed 2021;210:106354. [PMID: 34464768 DOI: 10.1016/j.cmpb.2021.106354] [Reference Citation Analysis]